Monoclonal
antibodies, raised against a purified GABA,/ benzodiazepine receptor complex from bovine cerebral cortex, have been used to visualize the cellular and subcellular distribution of receptorlike immunoreactivity in the rat CNS, cat spinal cord, and bovine and postmortem human brain. Two different antibodies have been used for these studies; bd-17 recognizes the b-subunit (/@ 55 kDa) in all the species tested, whereas bd-24 recognizes the a-subunit (iIf, 50 kDa) of bovine and human but not rat and cat tissues. In bovine and human brain, both antibodies produced very similar staining patterns, indicating a homogeneous receptor composition, at least in the brain areas investigated.
The general distribution and density of receptor antigenic sites in all tissues studied were very similar to that of benzodiazepine binding sites radiolabeled with 3H-Ro 15-1788 and of glutamate decarboxylase (GAD)-stained nerve terminals. The results demonstrate a very high receptor density (around neuronal cell bodies and processes or less discretely distributed) in the rat olfactory bulbs, cerebral cortex, ventral pallidum, islands of Calleja, globus pallidus, hippocampus, dentate gyrus, substantia nigra, geniculate nuclei, inferior colliculus, cerebellum, reticular formation, spinal cord, and retina. In contrast, no receptors could be detected in white matter, pineal, pituitary, adrenals, and superior cervical ganglia. Only among the cerebellar layers did we observe a conspicuous difference between the staining intensity and the radiolabeling.
In bovine and postmortem human brain, e.g., hippocampus, dentate gyrus, cerebral cortex, and substantia nigra, the same close correlation between the immunohistochemical and radiohistochemical findings was observed.
At the electron microscopic level, the immune reaction product in the rat substantia nigra and globus pallidus, for example, was localized to pre-and postsynaptic membranes of axodendritic and axosomatic synapses. Whether the presynaptic labeling represents GABA autoreceptors is discussed. In the near future, the monoclonal antibodies will be used in double-labeling experiments with GAD to identify those GABAergic projections that are modulated by benzodiazepine minor tranquillizers.
Furthermore, they could also be GABA, the major inhibitory neurotransmitter in many parts of the CNS (Roberts, 1986) acts through a so-called GABA, receptor to gate a coupled chloride channel. Ligands of the benzodiazepine receptor (Mohler and Okada, 1977; Squires and Braestrup, 1977) allosterically modulate the function of this receptor/channel complex. A unique feature of this modulatory component, which forms an integral part of the GABA, receptor complex, is its ability to mediate opposite pharmacological effects, by reducing or increasing GABAergic transmission, depending on the type of receptor ligand. The benzodiazepine minor tranquillizers trigger off their therapeutic effects by enhancing GABA, receptor function (see Haefely et al., 1985) . Previous attempts to map the distribution and density of benzodiazepine receptors in the CNS have used quantitative autoradiography with image analysis to evaluate in vitro or in vivo binding of radioligands in tissue sections (see Kuhar et al., 1986) . The limitations of such an approach (inherent poor resolution due to radiation scatter, ligand specificity, and possible ligand diffusion away from the binding site) are not encountered when using an immunohistochemical method. Monoclonal antibodies were recently raised against a purified GABA,/benzodiazepine receptor from bovine cerebral cortex. The antibodies reacted selectively with either the o(-or the P-subunit of the receptor complex (Hking et al., 1985; Schoch et al., 1985) . An immunohistochemical study was performed to visualize GABAJbenzodiazepine receptor antigenic sites in rat CNS, cat spinal cord, and bovine and postmortem human brain with a resolution hitherto not achieved by the radiohistochemical approach (Richards et al., 1986b) . A detailed cellular and subcellular localization of these receptors should help to identify the sites of GABAergic innervation in the brain that are modulated by benzodiazepines. Furthermore, since the antibodies were subunit specific, information about the receptor composition in different brain areas and species can be deduced.
Materials and Methods
Tissue preparation. Male albino SPF rats (specific pathogen free, Ftillinsdorf weighing 120 gm), cat spinal cord, and bovine and postmortem (3 hr) human brain were used. Rats were fixed by vascular perfusion (20 min) with an ice-cold solution of 2% formaldehyde (generated from paraformaldehyde powder) and 0.1% glutaraldehyde in PBS followed by immersion (2 hr) with agitation of tissues in the same fixative. Cat spinal cord and bovine and human brain were fixed by immersion (3 hr).
For light microscopy, all tissues were stored in ice-cold 20% sucrose in PBS (overnight), then frozen on microtome chucks in dry ice. Tenmicron cryostat sections were thaw-mounted onto acid-cleaned and subbed slides and then stored at 4°C until used. For electron microscopy, tissues were stored in ice-cold 7% sucrose in PBS (overnight), then 50 Km Vibratome sections were prepared.
Postmortem human brain was kindly provided by Prof. W. Wegmann, Institute of Pathology, Kantonsspital, Liestal.
Antibody preparation. Monoclonal antibodies were produced after immunizing mice with a highly purified GABA,/benzodiazepine receptor preparation from bovine cerebral cortex. The preparation and immunobiological characteristics of these antibodies have been recently described Haring et al., 1985; Mijhler et al., 1986) . Out of 16 different monoclonal antibodies distinguishing 4 different epitopes in the receptor complex, only 2 have been used for the present study. Antibody bd-17 is specific for the p-subunit (M, 55 kDa) and recognizes the human, bovine, cat, and rat receptor, whereas bd-24 is specific for the a-subunit (M, 50 kDa). It only recognizes the human and bovine receptor.
For comparison, some adjacent section surfaces were stained with an antibody to glutamate decarboxylase (GAD) (kindly provided by Dr. J. Y. Wu, Pennsylvania State University, Department ofPhysiology). Other serial sections were radiolabeled with 3H-Ro 15-1788 in vitro as previously described (Richards and Mdhler, 1984) . A further serial section was stained with cresyl violet for histological identification of the various tissues.
Immunohistochemical procedure. (1) Cryostat sections were incubated, according to the indirect peroxidase-antiperoxidase (PAP) technique (Stemberger, 1979) in sequence with the following reagents (Nordic Immunology) in PBS + 0.2% Triton at 20°C: 20% normai swine serum (30 min; Nordic), 50% hvbridoma supematant bd-17 or bd-24 (5-10 &ml) (overnight at 4°C g 2 hr at 20"(Z), 3.3% swine anti-mouse antiserum (30 min; Nordic) with 3 x 10 min PBS-Triton rinses between each incubation. This was then followed by incubation with 3.3% mouse PAP (30 min; Nordic), PBS-T&on (5 min), Tris buffer (+NaCl)-Triton (2 x 5 min), diaminobenzidine/Tris buffer (10.5 mg in 15 ml) with H,O, (15 min), distilled water rinse (5 min), dehydration, clearing, and mounting in DePex. Some sections were subsequently treated with 0.5% aqueous 0~0, for 20 set prior to dehydration. (2) Vibratome sections were incubated as above, but before dehydration and embedding in Epon, they were postfixed with 2% 0~0, in 0.1 M sodium cacodylate buffer at pH 7.4 (60 min at 4°C with agitation). Ultrathin sections were prepared of tissue proximal to the surface of the Vibratome slice.
The GAD antibody was diluted 1:400. Adsorntion controls were carried out with primary antibodies preincubated with a purified receptor preparation .
Microscopy. Immunoreacted cryostat sections were used as negatives for macroscopic images (resembling dark-field optics). They were also viewed and photographed with Zeiss bright-field, dark-field and interference contrast (Nomarski) optics. Counterstained or unstained ultrathin sections were examined with a Philips EM 300 electron microscope.
The rat brain stereotaxic atlas of Paxinos and Watson (1982) was used for reference. In addition, the following review articles were consulted: Shepherd, 1972; Macrides and Davis, 1983 (olfactory bulb); Emson and Hunt, 198 1; Pamavelas and McDonald, 1983; Schulman, 1983 (cerebral cortex); Lorente de No, 1934; Storm-Mathisen, 1978; Walaas, 1983; Schwerdtfeger, 1984; Teyler and Discenna, 1984 (hippocampus) ; Jones, 1983 (thalamus) ; Silverman and Pickard, 1983 (hypothalamus) ; Shiosaka et al., 1983. (amygdala) ; Palay and Chan-Palay, 1974 (cerebellum) : Hunt. 1983 : Molander et al.. 1984 (sninal cord): and Brecha, 1983 . ' \ -
Results
In agreement with previous immunobiochemical findings ( HBring et al., 1985; Schoch et al., 1985) , the 2 antibodies tested were found to be species specific. Thus, whereas bd-17 (a P-subunit specific antibody) was positive in the 4 species investigated, bd-24 (an a-subunit specific antibody) was negative in the rat and cat. However, in those species for which both bd-17 and bd-24 were immunoreactive, bovine and human brain, the staining patterns of the 2 antibodies were very similar, which is consistent with the concept of a hetero-oligomeric composition of the receptor containing LY-and P-subunits. Among the different brain regions investigated, no indication was found for a receptor heterogeneity at the level of the cy-and P-subunit composition.
Macroscopic pattern of immunoreactivity
We observed a marked heterogeneity in the pattern of immunohistochemical staining with the monoclonal antibodies in all tissues investigated.
Receptor immunoreactivity was concentrated in those regions of the CNS with a known GABAergic innervation (see Barber and Saito, 1976; Fagg and Foster, 1983; Ottersen and Storm-Mathisen, 1984; Wamsley and Palacios, 1984; Mugnaini and Oertel, 1985; Somogyi et al., 1985) and for which specific ligands (3H-Ro 15-l 788, -muscimol, -bicuculline and %-TBPS) of the GABA,/benzodiazepine receptor/Cl--channel complex are known to have a high affinity (see Young and Kuhar, 1979b and Kuhar, , 1980 Bowery et al., 1984; Miihler, 1984, 1985; Wamsley et al., 1985) . The general distribution of immunoreactive sites in the rat CNS, cat spinal cord, and bovine and postmortem human brain ( Fig. 1 ) compared favorably with that of benzodiazepine binding sites labeled in vitro with 3H-Ro 15-1788 published previously Schoch et al., 1985) .
Immunohistochemical findings
The immune reaction in the CNS was observed as a discrete staining of cell processes (presumably dendrites) and cell body profiles (presumably neurons) or a more diffuse granular staining. Immunoreactive cell processes were found in the internal plexiform and granular layers of the main and accessory olfactory bulbs, in the islands of Calleja, ventral pallidum, globus pallidus, hippocampus, dentate gyrus, substantia nigra reticular, cerebellar molecular layer, reticular formation, spinal cord, and retina. In several brain regions there was a more d@iise but granular immune reaction, e.g., in cerebral cortex, inferior colliculus, spinal cord (layers II, III; -substantia gelatinosa). In a few regions staining occurred around what appeared to be neuronal cell bodies, e.g., in the mitral cell, internal plexiform and granular layers of the olfactory bulb, in the anterior olfactory nucleus, islands of Calleja, pallidum, anterior commissure, hippocampus, dentate gyrus, substantia nigra reticular, cerebellum, reticular formation, spinal cord, and retina. As far as could be judged, immunoreactivity was rarely found within neurons and never in or around glial cells.
The following account describes (in a rostrocaudal sequence) representative examples of the immunohistochemical findings for the CNS of the 4 species investigated.
In the main and accessory olfactory bulbs, the external plexiform layer was the most intensely stained; there, as in the glomerular layer, the reaction was so intense that distinct fibers could hardly be resolved (Figs. lA, 2A ). In the mitral cell, internal plexiform, and granular layers, numerous cell profiles and processes were discretely stained (Fig. 2B) . Isolated immunoreactive cell profiles and their processes were present in the dorsal anterior olfactory nucleus. The olfactory nerve layer was devoid of an immune reaction.
Throughout the cerebral cortex ( Fig. 1 A) , the immune reaction was intense but diffuse. Discretely stained cells or cell processes were rarely observed. The finely granular immune reaction was notzbly weakest in layers I and V. The corpus callosum was not stained except for isolated cells and processes adjacent to layer VI. (lumbar -subunit- In pallidal regions (Figs. 3,4A), the islands of Calleja, ventral pallidum (substantia innominata) and globus pallidus were among the most discretely stained brain regions examined. In all these regions, isolated cell bodies and numerous processes were strongly immunoreactive on a virtually unstained background. In contrast, the caudate putamen ( Fig. 4A ) contained a very fine, diffuse immune reaction. Although the anterior commissure and internal capsule fibers were unstained, we frequently observed immunoreactive isolated cells and their varicose processes in the white matter (Fig. 4B ).
In the hippocampus and dentate gyrus ( Fig. 5 ), whereas the pyramidal and granule cell layers of these regions were only rarely stained, the oriens, radiatum, and lacunosum moleculare layers of the hippocampus and particularly the dorsal blade of the molecular layer in the dentate gyrus were characterized by an intense, finely granular immune reaction. Individual cell profiles and fibers were frequently stained in the outermost oriens layer and occasionally in the pyramidal cell layers; in the hilus, processes of immunoreactive cell profiles were observed projecting through the granule cell layer into the molecular layer of the dentate gyrus (Fig. 5C ). The CA3 region of Ammon's horn was distinctly less stained than the CA1 region (Fig. 5B) . The lower blade of the dentate gyrus molecular layer was invariably poorly stained. No staining was observed in the fimbria, alveolus, and subiculum.
The thalamus, particularly the rostra1 laterodorsal and lateroventral regions and the zona incerta (but not the epithalamic habenular nuclei), contained a moderate to intense finely granular immune reaction.
Most hypothalamic nuclei were finely stained throughout: Immunoreactive isolated cell profiles could be observed. The median eminence was generally devoid of an immune reaction.
Among the amygdaloid nuclei, the lateral amygdaloid nucleus was most intensely stained (finely granular immune reaction).
The substantia nigra, reticular area ( Fig. 6A ) contained a high density of intensely stained fibers and isolated cell profiles. The cerebral peduncle was not stained. In postmortem human brain ( Fig. 6B) , individual fibers and cells on an unstained background could be observed. Since highly stained pigmented cells were present even when the primary antibody was omitted, their staining was considered to be nonspecific.
The superficial layers of the superior and particularly throughout the inferior colliculi contained a finely granular immune reaction. The dorsal and median rapht? nuclei contained discretely stained fibers and a finely granular immune reaction. The nucleus of the dorsolateral lemniscus was intensely stained, but no individual fibers could be resolved.
In the cerebellum (Fig. 7) , whereas the granular layer (between and around the granule cells proper) was intensely immunoreactive, the Purkinje cell layer and white matter were unstained. In the molecular layer, however, discretely stained small cell profiles and fibers (occasionally appearing parallel, depending upon the plane of section through each lobule) were prominent features. The stained fibers appeared to extend to the surface of the lobules. Deep cerebellar nuclei (e.g., Deiters' nucleus) contained discretely stained fibers and cell profiles.
In the medulla, receptor antigenic sites were present on numerous cells and processes in the reticular formation (parvocellular, gigantocellular, oral, and caudal pontine nuclei) (Fig.  SA) .
The most prominent features in the spinal cord (Figs. 1 B, 8B) were the intense finely granular immune reaction in layers II-IV, as well as the numerous discretely stained fibers and isolated cells in layers VI-VIII and X. The ventral horn (particularly layer IX) and the funiculi were generally devoid of any staining except for isolated fibers that projected through layer IX and into the ventral funiculi. There was no visible staining around y-motor neurons.
In the retina (Figs. lC, 9 ), isolated, discretely stained cells occurred in the inner nuclear layer; they appeared to send single projections to the adjacent inner plexiform layer, where they seemed to branch and form a dense arborization with 3 distinct bands of a highly granular nature.
Among other tissues and organs investigated, the pineal, pituitary, adrenals, kidney, and superior cervical ganglia were devoid of a visible immune reaction light microscopically.
Immunocytochemicaljndings
The subcellular distribution of immune reactivity in the rat substantia nigra (reticular zone) and globus pallidus was studied by electron microscopy. A distinct, highly electron-dense reaction product was observed exclusively in axodendritic and the oc- (dark areas) in rat olfactory bulb using mAb bd-17 (bright-field optics). Note the intense staining of the external plexiform and glomerular layers but the absence of stain in the olfactory nerve layer (A). At higher magnification (B), mitral cell profiles also appear highly stained. Bars, 50 pm. in an island of Calleja and ventral pallidurn, respectively, of a rat using mAb bd-17 (bright-field optics). Note the numerous immunoreactive fibers in both regions. A cell profile (arrow) in A is also clearly stained. In the nucleus accumbens rostra1 to the pallidum (B), the immune reaction is, in contrast, extremely fine. Bars, 50 pm. Figure 4 . Microscopic distribution of immunoreactivity in rat globus pallidus, caudate putamen, and anterior commissure using mAb bd-17 (Norma&i and bright-field optics, respectively). Note the intensely stained fibers and occasional cells (arrows) in the globus pallidus compared to the finely stained caudate putamen. Internal capsule fibers are free of stain. The anterior commissure (B) contains a discretely immunoreactive cell and several varicose processes. Bars, 50 pm. Figure 5 . A, Schematic illustration of the principal structural features of the hippocampal formation. B and C, Macroscopic and microscopic distribution of immunoreactivity in rat hippocampal formation (white areas) and bovine dentate gyms (dark areas), respectively, using bd-17. Note the intense staining in the various layers (CA1 > CA3) and the virtual absence of stain in the pyramidal and granule cell layers, fimbria and alveus. In the dentate gyms (C, Normarski optics), several immunoreactive cell profiles and their processes are present in the hilus just below the granule cell layer. Bars, 2 mm (B), 50 pm (C).
casional axosomatic synaptic contacts in lightly counterstained (Fig. 10) or unstained sections. The immune reaction was present not only on the postsynaptic membrane but also presynaptically. Most of the immunoreactive axodendritic synapses were on medium to large dendrites and only few were present on small dendritic spines.
Discussion
Receptor mapping with an anatomical resolution was revolutionized by the introduction, some 7 years ago, of a radiohistochemical technique for in vitro binding studies of neurotransmitters and drugs (Young and Kuhar, 1979a; Kuhar et al., 1986) . While this is clearly still the method of choice for qualitative and quantitative anatomical studies of the pharmacology of receptors in vitro and, more recently, also in vivo (Goeders and Kuhar, 1985; Ciliax et al., 1987; Richards et al., unpublished observations), an immunohistochemical approach would have a number of advantages; in particular, the problems of the specificity of ligand binding, ligand diffusion, and radiation scatter encountered with the radiohistochemical technique are overcome. Receptor antigenic sites for glycine and ACh (nicotinic) receptors have been visualized by nondiffusible markers such as peroxidase-coupled or colloidal gold-coupled secondary antibodies (Lentz and Chester, 1977; NghiCm et al., 1983; Sealock et al., 1984; Triller et al., 1985) .
In the present study, monoclonal antibodies were used that had been raised against an isolated partially purified GABA,/ benzodiazepine receptor from bovine cerebral cortex Haring et al., 1985) . Out of the hybridoma cultures, we chose 2 secreting species-and subunit-specific antibodies (bd-17 and bd-24; isotype IgGl), for extensive mapping of receptorlike immunoreactivity in rat CNS, cat spinal cord, Comparing the overall radio-and immunohistochemical patterns of benzodiazepine receptor distribution with that of GABAergic nerve terminals (Young and Kuhar, 1980; Richards and Mohler, 1984; Mugnaini and Oertel, 1985; Richards et al., 1986a) , we conclude that, with a few exceptions, there is a good correspondence.
Cellular localization of receptors In many regions of the CNS, receptor antigenic sites were found predominantly on neurons and dendrites; in some regions, their cellular localization could not be resolved light microscopically. In discussing the cellular localization of benzodiazepine receptors, we will describe those regions of the CNS whose GABAergic innervation and receptors, electrophysiology, or pharmacology are reasonably well documented and that have a moderate to high density of benzodiazepine receptors Kuhar, 1979b, 1980; Richards and Mohler, 1984; Wamsley and Palacios, 1984; Haefely and Pole, 1986; Richards et al., 1986~) .
Olfactory bulbs
The main and accessory olfactory bulbs contained by far the highest density of receptor antigenic sites in the CNS. In correlation with the distribution of GABAergic nerve terminals was the intense staining of the glomerular and external plexiform layers. Benzodiazepine receptors are probably located on primary and secondary mitral cell dendrites which receive GABAergic nerve terminals from periglomerular and granule cells (Nicoll, 1971; Ribak et al., 1977; Halasz et al., 1979; Jaffe and Cuello, 1980, 198 1; Jaffe et al., 1983; Mugnaini and Oertel, 1985) . The nonimmunoreactive olfactory nerve layer contains neither GABAergic nerve terminals nor central-type benzodiazepine receptors but a high density of peripheral-type (glial?) receptors (Richards et al., 1982 . From the staining pattern, it appears that receptors are present also on mitral cells, some granule cells, and isolated cells and their processes in the lateral olfactory tract whose synaptic connections are as yet unknown. Ontogenetically, benzodiazepine receptors appear in the olfactory bulbs (more prominently in the accessory olfactory bulbs) by gestational day 16 (Schlumpf et al., 1983) , which is precisely when receptors can be first detected immunohistochemically (unpublished observations).
GABAergic inhibitory mechanisms probably play a prominent role in the modulation of olfactory sensation in rodents (see Halasz and Shepherd, 1983) . The effect of benzodiazepines in the bulbs has not been investigated, although barbiturates have been shown to enhance the GABA-mediated depression of mitral cell excitability (in the rabbit) that follows an antidromic mitral cell action potential induced by stimulation of its axon in the lateral olfactory tract (see Nicoll, 1980) . Changes in olfactory perception do not seem to have been observed with barbiturates or benzodiazepines in man, which may mean that ongoing GABAergic inhibition is almost maximal so that any slight enhancement induced by the benzodiazepines would be difficult to observe.
The distribution of receptor antigenic sites in the hippocampus and dentate gyrus is consistent with a high density of receptors on pyramidal and granule cell dendrites (finely granular immune reaction), as well as on isolated neurons and their processes in the oriens layer and in the hilus of the hippocampus and dentate gyrus, respectively. The comparatively low density on pyramidal and granule cell perikarya, despite electron microscopic evidence for GABAergic nerve terminals on these cells (Somogyi et al., 1983; Mugnaini and Oertel, 1985) , suggests either receptor heterogeneity or the sensitivity of the method is insufficient to detect such a density (at least at the light microscopic level). Radiolabeled benzodiazepine receptors have been found in the oriens, radiatum, and lacunosum moleculare layers of the hippocampus and in the molecular layer of the dentate gyrus (Young and Kuhar, 1980; Richards and Miihler, 1984; Richards et al., 1986~) ; the density is much lower in the pyramidal and granule cell layers. No receptors occur in the fimbria and alveolus, and a moderate to low density occurs in the subiculum. The consistently lower density of receptor antigenic sites in the CA3 region of the hippocampus compared with the CA1 region reCerebral cortex The cerebral cortex, another brain region rich in benzodiazepine veals possible differences in the GABAergic innervation of pyand GABA, receptors, contained an intense, finely granular imramidal cell dendrites (and their sensitivity to benzodiazepines?) mune reaction; cell profiles and processes could not be resolved. From radiohistochemical studies, benzodiazepine (and GABA,) receptors are known to be concentrated in particular laminae of rat brain (IV > I, VI >> II, III, V) and of human calcarine cortex (III, IVA, IVC) Kuhar, 1979b, 1980; Richards and Mohler, 1984; Richards et al., 1986~) . Receptor antigenic sites were concentrated in laminae II, III, IV, and VI; in other words, they were more homogenously distributed than would be expected from radiohistochemical observations. Among GABAergic cortical neurons, aspinous and sparsely spinous stellate cells in the visual cortex branch profusely in lamina IV (Ribak, 1978) , where the GABA concentration is reported to be highest (Ishikawa et al., 1983) ; all stellate neurons are apparently inhibitory.
Inhibition of cortical pyramidal neurons is mediated by GABA (see Haefely and Pole, 1986) . Ribak (1985) has recently observed that inhibitory GABAergic nerve terminals of chandelier cells, for example, in monkey sensorimotor cortex decrease at sites of focal epilepsy.
Pallidal regions
The islands of Calleja, ventral pallidum, and globus pallidus were intensely and discretely immunoreactive, corresponding to the dense GABAergic innervation of large dendrites and occasional neurons in these areas. Fallon et al. (1983) have described symmetrical synapses that encircle smooth pallidumtype dendrites of larger cells in the islands of Calleja. In marked contrast to these regions was the very fine immune reaction in the caudate putamen and nucleus accumbens, which correlates well with the intensity of GAD immunoreactivity in these areas (Ribak et al., 1979; Mugnaini and Oertel, 1985) . The receptor antigenic sites on isolated neurons and their varicose processes in the white matter of the anterior commissures and internal capsule fibers were unexpected. Presumably because of the sparse distribution of these neurons, neither GAD nor benzodiazepine binding sites have previously been reported to occur in these regions; the synaptic connections of these neurons are not known.
Hippocampal formation in these regions. The identity of the immunoreactive cells and their processes in the oriens layer and hilus is not known.
Benzodiazepines enhance recurrent inhibition in the hippocampus (see Alger and Nicoll, 1982; Haefely and Pole, 1986) . Their marked effects in this brain region point to a significant contribution to the anticonvulsant and anxiolytic activity and perhaps to the induction of anterograde amnesia. Recently, Peterson and Ribak (1986) have described morphological evidence for increased inhibition of basket cells in the dentate gyrus of seizure-sensitive mongolian gerbils; whether the receptor immunoreactive cell profiles in the hilus of rat and bovine and postmortem human dentate gyrus are indeed basket cell neurons is currently being investigated by double-labeling with GAD and receptor antibodies.
Thalamus
In the thalamus, the presence of a high density of receptor antigenic sites in some regions (rostra1 dorso-and ventrolateral nuclei) is consistent with the property of benzodiazepines to prevent the spread of seizures from this brain area. Electrophysiological studies focusing on their GABA-potentiating action in the thalamus are lacking.
Hypothalamus
The hypothalamic nuclei, including those related to feeding behavior (lateral and ventromedial nuclei) (Kelly and Grossman, 1980; Morley et al., 1984) , were moderate to poorly but evenly stained. GAD is also reported to be evenly distributed in the hypothalamus (Mugnaini and Oertel, 1985) . Surprisingly, the median eminence, which is known to have a dense GABAergic innervation, was virtually devoid of receptor antigenic sites. GABA is probably released into the portal system to reach receptors on pituitary cells.
The effects of benzodiazepines in reducing several behavioral, autonomic, and endocrine responses to emotional stimuli may be due in part to their action on GABAergic synapses in the hypothalamus. The regulation of feeding behavior by the lateral and ventromedial hypothalamus is indirectly under the control of GABAergic inhibition; benzodiazepines are known to stimulate feeding behavior (food intake).
Amygdala
In the amygdala, the basolateral nucleus has been found to contain a high density of benzodiazepine receptors in rat and human brain Niehoff and Whitehouse, 1983 ) and, indeed, the lateral nucleus contained the most receptor antigenic sites.
The lateral and basolateral nuclei have been implicated in the anticonflict effect of benzodiazepines mediated by specific benzodiazepine receptors (Petersen et al., 1985) . Diazepam depresses the spontaneous firing of neurons in the amygdala (Chou and Wang, 1977) , which is probably mediated by GABAergic interneurons.
Substantia nigra
The substantia nigra, reticular area, contains a high density of benzodiazepine receptors, most of which are on dendrites, some on neurons. Major GABAergic projections to this area derive from the striatum and globus pallidus (Fonnum et al., 1978; Nagy et al., 1978; Ribak et al., 1980; Araki et al., 1985) ; there is also evidence for a nigrothalamic GABAergic pathway (Straughan et al., 1980) . A considerable part of the dendritic region of A9 dopaminergic neurons of the substantia nigra compacta extends into the reticular area, where they synapse with GABAergic nerve terminals (Van den Pol et al., 1985) . Up to 50% of all nerve terminals in the substantia nigra are GAD positive (on cell bodies and dendrites) (Ribak et al., 1976 (Ribak et al., , 1980 Berod et al., 1984) . In both rat and human brain, the reticular part of the substantia nigra contained numerous receptor-immunoreactive large dendritic profiles and the occasional cell body profile.
Benzodiazepines enhance GABAergic inhibition of both dopaminergic and GABAergic output neurons (see Mereu and Biggio, 1983) . The depression of the excitability of nigral reticular (dopaminergic?) neurons by GABAergic mechanisms may be relevant to the anticonvulsant activity of benzodiazepines.
Colliculi
Benzodiazepine receptor antigenic sites were highly concentrated in the superficial superior colliculus (layers I-III) and throughout the inferior colliculi; these brain areas are associated with visual and auditory pathways, respectively. The dorsal nucleus of the lateral lemniscus, a precollicular nucleus whose majority of neurons are GAD positive and which is a major GABAergic feed-forward inhibitory center in the auditory pathway (Adams and Mugnaini, 1984) also had a high density of receptor-immunoreactive sites.
Cerebellum
In the cerebellum, the distribution of receptor antigenic sites is compatible with their localization on Purkinje cell dendrites and on isolated (stellate or basket?) cell bodies in the molecular layer, as well as in glomeruli and on granule cells in the granule cell layer. Purkinje cells, Golgi, basket, and stellate cells are known to be GABAergic. Golgi and Purkinje cells are GAD positive. In the granule cell layer, Golgi nerve terminals form a circle of GAD-positive nerve terminals on granule cell dendrites (Saito et al., 1974) . Nerve terminals on dendritic trunks (more than spines) of Purkinje cells, basket cells, and stellate cells are also GAD positive. The unexpectedly high density of immunoreactive sites in the granular, as compared with the molecular, layer [correlating with the distribution of high-affinity GABA (muscimol) and TBPS binding sites, but not with that of radiolabeled benzodiazepine receptors and low-affinity GABA (bicuculline) binding sites] (Palacios et al., 198 1 [Wamsley et al., 1985) , might be due to the fact that with our monoclonal antibody we are visualizing both high-and low-affinity conformational states of GABA, receptors in the cerebellum (and other regions of the CNS). The exceptionally high density of high-affinity GABA, receptors in the granular layer of the cerebellum, which might contain low-affinity benzodiazepine binding sites, produces the apparent discrepancy. A structural difference between receptors in cerebellum and other brain regions was recently described (Sweetnam and Tallman, 1986) . Recently, Fry et al. (1985) demonstrated that, in Lurcher mutant mice (deficient in Purkinje cells and the majority of granule cells), 3H-muscimol binding was 25% of control littermates, although 3H-flunitrazepam binding was unchanged, these findings are difficult to reconcile with ours.
One of the major functions of the cerebellum is the control of muscle tone and coordination. Benzodiazepines enhance synaptic inhibition of Purkinje cells by stellate and basket cells. It is therefore tempting to associate the muscle relaxant (antispastic), as well as the ataxic, effects of benzodiazepines with GABAergic synapses in the cerebellum.
In deep cerebellar nuclei and lateral vestibular nucleus, receptor antigenic sites were found around large (Deiter?) neurons. The deep cerebellar nuclei and vestibular nuclei are important sites for the depressant actions of benzodiazepines on the crossed extensor reflex (Kawasaki et al., 1984) . Secondary vestibular neurons receive postsynaptic inhibition from the GABAergic Purkinje cells in the cerebellar cortex, and there is evidence for an intrinsic GABAergic innervation (Houser et al., 1984) . The circuit is involved in modulating various vestibular reflexes that mediate equilibrium and eye movements. A depression of the excitability of secondary vestibular neurons by enhancement of the GABAergic input from the cerebellar cortex may explain a beneficial effect of benzodiazepines on some forms of vertigo; it may also contribute to the ataxia produced by higher doses of these drugs (see Haefely and Pole, 1986) .
Medulla
The high density of receptors in the reticular formation is compatible with the muscle-relaxant properties of the benzodiazepines. Muscle tone is thought to be controlled in part through polysynaptic reflexes in the reticular formation, as well as through cerebellar Purkinje cell activity.
Spinal cord
In the spinal cord, the distribution of receptor antigenic sites, similar to that of radiolabeled receptors (Young and Kuhar, 1980; Richards and Mohler, 1984; Faull and Villiger, 1986; Richards et al., 1986~) is compatible with the presence of receptors in high density in the substantia gelatinosa (layers II, III) and layers IV and X, as well as on isolated cells and processes in layers VI-VIII. In other words, they are present in the terminal fields of primary afferent axons in the dorsal horn and around the central canal where GAD-positive terminals are concentrated (McLaughlin et al., 1975) . Since some GABAergic nerve terminals are reported to be presynaptic to primary afferent terminals (Barber et al., 1978 ) the subcellular distribution of receptor antigenic sites in the spinal cord is currently being investigated after capsaicin administration or unilateral rhizotomy. The identity of the immunoreactive cells and processes in layers VI-VIII is not known. They are tentatively identified as small-to medium-size motor neurons and their large dendrites (see McLaughlin et al., 1975) . Peripheral-type binding sites in the spinal cord are more evenly distributed (Villiger, 1984; Richards et al., 1986~) .
Primary efferent depolarization is probably mediated by GABA (see Haefely and Pole, 1986) . Benzodiazepines increase the amplitude and/or duration of dorsal root potentials and accentuate and prolong the presynaptic inhibition of monosynaptic reflex responses. The influence of benzodiazepines on synaptic transmission and sensorimotor effects of these drugs on transmission in sensory pathways projecting towards the brain has been extensively investigated. A clear antinociceptive activity of benzodiazepines has not been described.
Retina
The vertebrate retina, an extracranial derivative of ectoderm that arises from an outpouching ofthe diencephalon during early embryogenesis, contains a localized concentration of centraltype benzodiazepine receptors (Howells et al., 1979; Paul et al., 1980; Brecha, 1983) . The distribution of receptor antigenic sites is consistent with the presence of receptors on a subpopulation of amacrine cells (and some ganglion cells) and their dense arborizations in 3 main bands in the inner plexiform layer.
Benzodiazepine binding in the retina shows all the characteristics of brain receptors (ligand specificity, GABA modulation). Horizontal cells and a subpopulation of amacrine cells are GABAergic (Brandon et al., 1979; Vaughn et al., 1981; Wu et al., 1981; Schnitzer and Rusoff, 1984; Brandon, 1985) . GAD activity is present in 4 distinct bands in the inner plexiform layer and in displaced amacrine cells. Amacrine cell processes arborize within selected laminae of the inner plexiform layer and synapse with amacrine, ganglion, and bipolar cells. As far as could be determined in double-labeling experiments and in adjacent sections, the receptor-immunoreactive bands in the inner plexiform layer of the rat retina were present in GADpositive bands, although the latter were rather wider and perhaps more diffuse (see Fig. 9C ). This finding suggests that, in the rat retina, all benzodiazepine receptors are associated with GABAergic nerve terminals. Ultrastructural studies are required to confirm this finding.
The functional role of GABAergic synapses in the transmission between photoreceptors and bipolar and ganglion cells is still unknown; GABA is reported to mediate inhibition of ganglion cells in the cat retina (Ikeda and Sheardown, 1983; Bolz et al., 1985) . Benzodiazepines attenuate the light-induced increase in dopamine turnover in a subpopulation of amacrine cells (Kamp and Morgan, 1982) . In retinae of 25-d-old darkadapted rats, a 30-40% increase in benzodiazepine binding was observed (Biggio et al., 198 1; Rothe et al., 1985) . Furthermore, a 25% decrease in binding occurred in the open eyes of rats with monocular deprivation. Whether therapeutic doses of benzodiazepines affect retinal function is not yet known. Although retinal GABAergic mechanisms might be involved in visual symptoms reported during benzodiazepine withdrawal, changes in visual perception do not seem to have been observed during benzodiazepine therapy in man. No overt effects on electroretinograms have been observed in studies on rabbits (Laurent, unpublished observations), although subtle effects cannot be excluded.
Pineal
In accordance with the lack of radiolabeled benzodiazepine receptors in rat pineal was the absence of receptor antigenic sites in this part of the epithalamus. A GABAergic innervation and GABA receptors are also lacking. Since neuronal-type benzodiazepine receptors are reported to be present in human pineal (Lowenstein et al., 1985) species differences obviously occur. A high density of non-neuronal binding sites occurs in rat pineal (Richards and MBhler, 1984; Richards et al., 1986~) ; they probably mediate the benzodiazepine-induced potentiation of norepinephrine stimulation of melatonin synthesis (Mathew et al., 1984 (Brown and Martin, 1984) . This finding has been confirmed using a LZ51-labeled benzodiazepine receptor ligand (Richards and Sequier, unpublished observations) . Only the neurointermediate lobe contains GABAergic nerve terminals (Oertel et al., 1982) . The anterior lobe is not innervated but is regulated by hypothalamic release-regulating factors (including GABA?) via the portal vessels (Racagni et al., 1982) . Peripheral-type (glial?) binding sites are highly concentrated in the neural lobes (presumably on pituicytes) (De Souza et al., 1985; Richards et al., 1986~) .
The release of melatonin-stimulating hormone is reported to be stimulated by exogenous GABA (Tomiko et al., 1983) ; accordingly, rat melanotrophs appear to possess GABA receptors (Taraskevich and Douglas, 1985) . Thus, these findings, as well as the reported presence of GABA receptors (Anderson and Mitchell, 1983) and GABA-related chloride channels (Anderson et al., 1985) in the anterior lobe and the benzodiazepine enhancement of muscimol-stimulated prolactin release Mitchell, 1983, 1984; Schettini et al., 1984) , are compatible with the presence of a small number of GABA, and benzodiazepine receptors in the anterior and intermediate lobes.
Peripheral tissues
Receptor antigenic sites could not be detected in the tissues investigated (sympathetic ganglia, adrenals, kidneys). Despite increasing evidence for the presence of GABA (perhaps as a neurotransmitter) in certain peripheral tissues (see ErdG, 1985) their GABA receptors are not usually coupled to benzodiazepine receptors.
However, although sympathetic ganglion cells (e.g., in superior cervical ganglia) are not innervated by GABAergic nerve terminals, the cells have GABA receptors and respond to GABA mimetics with a bicuculline-sensitive depolarization (see Little, 1984) . Possible receptor-mediated benzodiazepine effects have also been observed. Moreover, histochemical and biochemical studies (Kataoka et al., 1984) have revealed that bovine adrenal chromaffin cells contain GABA, GAD, and GABA-T. In addition, the presence of GABA, and benzodiazepine receptors (although not extensively characterized) has been revealed biochemically by radioligand binding studies. Recently, chlorideselective, bicuculline-sensitive GABA-receptor channels were demonstrated (electrophysiologically) in adrenomedullary chromaffin cells (Bormann and Clapham, 1985) ; GABA-induced currents were potentiated by diazepam. The apparent discrepancy between these findings and our negative observations might be explained by a different receptor sensitivity and extremely low density in peripheral tissue sections or even by the presence of a different receptor protein.
Subcellular localization of receptors A variety of approaches has been used to identify specific parts of cell-surface membranes as the subcellular binding sites of receptor ligands. (1) Photoaffinity ligands that become covalently (irreversibly) bound when exposed to ultraviolet light have been used to photolabel benzodiazepine receptors, e.g., with 3H-flunitrazepam, 3H-clonazepam, and 3H-Ro 15-45 13 (a partial inverse agonist derived from Ro 15-1788) (Miihler et al., 1980 (Miihler et al., , 1981 (Miihler et al., , 1984 Sieghart et al., 1987) . (2) Other ligands that become irreversibly bound when crosslinked with glutaraldehyde fixative have been described by Hamel and Beaudet (1984a, b) for the localization of opioid receptors.
However, radiohistochemical studies at an ultrastructural level still suffer from the same limitations in resolution of the autoradiographic approach, namely, radiation scatter, diffusion, and nonspecific binding of the radioligand. Thus, using 3H-flunitrazepam as a photoaffinity label, we were able to determine the probability of benzodiazepine receptors occurring in regions of synaptic contacts (Mohler et al., 1980) , some of which were GABAergic (Mohler et al., 198 1) . However, the receptors could not be attributed to specific neuronal membranes.
Receptor localization by immunocytochemistry overcomes the limitations in resolution of the radiohistochemical technique. As previously mentioned, receptors for dopamine, glytine, and ACh (nicotinic) have been visualized by nondiffusible markers such as peroxidase-coupled or colloidal gold-coupled secondary antibodies (Lentz and Chester, 1977; Goldsmith et al., 1979; NghiCm et al., 1983; Sealock et al., 1984; Triller et al., 1985) .
In the present study we have visualized the subcellular distribution of benzodiazepine receptors in rat substantia nigra and globus pallidus. Receptor antigenic sites were confined to preand postsynaptic membranes of axodendritic and axosomatic contacts. This finding is in line with previous observations by Lo et al. (1983) that benzodiazepine receptor ligands might modulate not only a postsynaptic GABA, receptor complex (Trifiletti and Snyder, 1985) but also a presynaptic GABA receptor, presumably GABA autoreceptors (Mitchell and Martin, 1978; Kuriyama et al., 1984; Lockerbie and Gordon-Weeks, 1985; Tietz et al., 1985) . However, since diffusion ofthe enzyme (PAP) reaction product from the post-to the presynaptic membrane might conceivably occur (see Landis, 1985) the presynaptic localization will have to be confirmed (e.g., by the use of a goldlabeled secondary antibody as marker and by in situ hybridization). New views on the mechanism of action of benzodiazepine receptor ligands would open up should this finding also hold true for other regions of the CNS.
In conclusion, the present findings on the cellular and subcellular distribution of receptor antigenic sites in the mammalian CNS, reveal the precise target sites for the actions of benzodiazepines in the CNS. In the near future we hope to identify the transmitter(s) of these target cells in double-labeling experiments using, for example, GAD; tyrosine hydroxylase, and 5-hydroxy tryptamine antibodies with our receptor monoclonal antibody. In this way, we hope to determine (electron microscopically) whether all benzodiazepine receptors are associated with GABAergic synapses. Investigations are also in progress to study the receptor antigenic sites in human brain biopsies and postmortem tissue of patients with, for example, epilepsy or chronic anxiety. Such studies might reveal pathological changes in the receptor that could underlie such CNS disease states (see Whitehouse, 1985; Chugani and Olsen, 1986) . Finally, cDNA and cRNA probes will soon become available for the identification of those target cells expressing the receptor (in situ hybridization studies). This approach could also be used to demonstrate whether the receptor is regulated at the level of the genome, for example, in cases of acute or chronic drug tolerance. 
